0001209191-19-047753.txt : 20190829 0001209191-19-047753.hdr.sgml : 20190829 20190829182654 ACCESSION NUMBER: 0001209191-19-047753 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190828 FILED AS OF DATE: 20190829 DATE AS OF CHANGE: 20190829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Salter-Cid Luisa CENTRAL INDEX KEY: 0001766404 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38796 FILM NUMBER: 191067502 MAIL ADDRESS: STREET 1: C/O GOSSAMER BIO, INC. STREET 2: 3013 SCIENCE PARK ROAD, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gossamer Bio, Inc. CENTRAL INDEX KEY: 0001728117 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475461709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 922-0718 MAIL ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-28 0 0001728117 Gossamer Bio, Inc. GOSS 0001766404 Salter-Cid Luisa 3013 SCIENCE PARK ROAD SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2019-08-28 4 S 0 23748 19.6532 D 150308 D Common Stock 2019-08-29 4 S 0 26252 20.0868 D 124056 D The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.50 to $19.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 97,908 shares subject to forfeiture, which shares will vest in equal monthly installments as set forth in the restricted stock agreement between the Issuer and Reporting Person so that all of the shares will be released from the forfeiture restriction on November 20, 2021, subject to the Reporting Person's continuous service to the Corporation on each such vesting date. The shares are also subject to certain accelerated vesting provisions as set forth in more detail in the employment agreement between the Issuer and the Reporting Person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.71 to $20.42 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Jeff Boerneke, Attorney-in-Fact 2019-08-29